The culmination of the promise of a new male contraceptive is near to come.

Elaine Lissner, director of the nonprofit Male Contraception Information Project, is cautiously optimistic. "The Holy Grail of contraception is a long-term, reversible method without any hormonal side effects," she said.

The new male contraceptive researchers very recently have been approved by the USFDA to go ahead with the 90-man study of the Intra Vas Device (IVD). IVD is a non-hormonal contraceptive that stops sperm in their tracks; a male contraceptive method that is reversible unlike vasectomy.

Men don't have to wait long, before they knew it, the IVD once approved will be available to patients.

Read more at EurekAlert.